KLP Kapitalforvaltning’s Amedisys AMED Stock Holding History

KLP Kapitalforvaltning’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,000	Closed	-$689K	–	2172
2025 Q2	$689K	Buy	7,000 +500	+8%	+$47.3K	﹤0.01%	1180
2025 Q1	$602K	Hold	6,500	–	–	﹤0.01%	1200
2024 Q4	$590K	Buy	+6,500	New	+$597K	﹤0.01%	1277

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

KLP Kapitalforvaltning's AMED Position: Q3 2025 in Review

KLP Kapitalforvaltning sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,000 shares — an estimated $689K sold.

KLP Kapitalforvaltning first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $689K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

KLP Kapitalforvaltning reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
KLP Kapitalforvaltning sold 7,000 Amedisys shares in Q3 2025, an estimated $689K.
KLP Kapitalforvaltning first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
KLP Kapitalforvaltning's Amedisys position peaked at $689K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2025, filed 23 Oct 2025.